Curepro Parenterals Limited - Company overview

Curepro Parenterals Limited is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN U24232TG2013PLC087101).…

2013-04-19 Hyderabad, Telangana Amalgamated Unlisted Active Compliant
View plans
CP Curepro Parenterals Limited
Complete Company Report + Documents
  • MCA filings & documents
  • P&L, balance sheet, cash flow & ratios
  • Year-wise charts & analysis
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
MCA Documents Access
  • Public filings
  • Bulk ZIP download
  • Dashboard access (1 year)
₹300 ₹149 50% off New user
Or enjoy up to 50% off with credits View credit packages

Key Metrics

AUTHORISED CAPITAL
20.00 cr
PAID-UP CAPITAL
13.31 cr
COMPANY AGE
13 Years 1 Months
since 2013-04-19
LAST FILING WITH ROC
2020-03-31
Last AGM: 2020-08-24
OPEN CHARGES
-
-
SATISFIED CHARGES
-
-
REVENUE
PROFIT / LOSS
EBITDA
NET WORTH
TOTAL ASSETS
TOTAL MONEY RAISED
ACTIVE GST
-
Updated: 2023-02-23 23:54:39

About Curepro Parenterals Limited

Curepro Parenterals Limited is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN U24232TG2013PLC087101). Business overview includes Pharma (Drug Formulation & Development), incorporated on April 19, 2013 (13+ years old), headquartered in Hyderabad, Telangana, India. The company is currently Amalgamated with Active Compliant compliance status. It has 6 active directors.

Drug Formulation & Development
  • Location Plot No.2, Maitrivihar Ameerpet, Hyderabad, Telangana - 500038
  • Website aurobindo.com
CIN / LLPINU24232TG2013PLC087101
Company No.087101
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date2013-04-19
Date of AGM2020-08-24
Date of Balance Sheet2020-03-31
Listing StatusUnlisted
ROC CodeRoc Hyderabad
PAN
LEI Number
Active ComplianceActive Compliant

Financial Performance of Curepro Parenterals Limited

Revenue Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▲ 38.3% Growth (3 Year) ▼ -9.9%
Profit/Loss Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▼ 65.1% Growth (3 Year) ▼ 60.7%
Values are in Mixed (K, L, Cr)
Metrics FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Revenue 2,20,083.04 cr2,35,431.21 cr2,51,890.00 cr2,18,400.00 cr1,95,200.00 cr1,72,000.00 cr1,59,000.00 cr
Profit/Loss 13,969.70 cr 4,810.00 cr 12,200.00 cr 9,100.00 cr -8,200.00 cr 3,200.00 cr 5,100.00 cr
Cash & Bank Balance 38,200.00 cr35,100.00 cr32,000.00 cr28,500.00 cr25,200.00 cr22,000.00 cr19,800.00 cr
Net Worth 1,26,731.94 cr1,37,500.00 cr1,40,200.00 cr1,28,000.00 cr1,15,000.00 cr1,02,000.00 cr95,000.00 cr
EBITDA 27,865.49 cr29,800.00 cr30,200.00 cr27,000.00 cr24,500.00 cr22,000.00 cr20,100.00 cr

Financial Ratios

Revenue P/L EBITDA

Values in Crores (Cr) - illustrative trend

FY 2021 - FY 2025
Key Insights (FY 2025)
Revenue2,20,083.04 cr ▼ 6.5%
Profit/Loss13,969.70 cr ▲ 190.6%
EBITDA27,865.49 cr
Net Profit Margin10.54%
Debt/Equity0.47
Current Ratio0.88
Return on Equity12.3%
Ratio FY 2025FY 2024FY 2023FY 2022FY 2021
Net Profit Margin10.543.202.101.800.50
Debt to EBITDA2.141.901.701.501.20
Interest Coverage Ratio0.470.500.450.400.35
Debt to Equity0.880.900.850.800.75
Return on Equity12.103.002.001.500.20
Current Ratio1.201.151.101.050.99
Quick Ratio0.950.920.880.850.80
EBITDA Margin12.0010.008.007.005.00
Return on Capital Employed8.002.001.000.200.00
Earning Per Share4.000.000.000.000.00

Shareholding Pattern

Shareholding Pattern (FY 2025)
  • Promoters 33.19%
  • DII 23.22%
  • FII 18.28%
  • Public 22.89%
  • Others 2.42%
Shareholding Pattern over the Year
Category 20252024202320222021
Promoters33.19%33.50%33.80%34.00%34.41%
DII23.22%22.90%22.50%22.10%21.80%
FII18.28%18.00%17.60%17.20%16.90%
Public22.89%23.10%23.50%24.00%24.20%
Others2.42%2.50%2.60%2.70%2.69%
Subsidiaries Company (6)
TAYO ROLLS LIMITED
54.91% held
THE TATA PIGMENTS LIMITED
100% held
CERAMAT PRIVATE LIMITED
90% held
BHUSHAN STEEL (SOUTH) LIMITED
100% held
NEELACHAL ISPAT NIGAM LTD
99.68% held
TATA STEEL DOWNSTREAM PRODUCTS LIMITED
100% held

EPFO Establishments (1)

MRNOI0019835000 Closed/All Member Excluded
StatusCode No Allotted Was Before Online Registration Started.
ActivityPaper
StateUttar Pradesh
Coverage07-JUN-1995

Current Directors (6)

M
Director | Since 2013-08-21
S
Director | Since 2015-06-25
S
CFO | Since 2020-05-21
B
Whole-time director | Since 2019-05-27
V
Company Secretary | Since 2019-06-10
S
Director | Since 2013-09-12

Business Activity

Activity GroupDescriptionTurnover %
Manufacturing-0

Flagged By Authority

Regulatory and exchange flags (preview)

Frequently Asked Questions about Curepro Parenterals Limited
What is CIN of Curepro Parenterals Limited?
The Corporate Identification Number (CIN) for Curepro Parenterals Limited is U24232TG2013PLC087101. CIN is a distinct identification code allotted by the Registrar of Companies (ROC) under the Ministry of Corporate Affairs (MCA). The company registration number is 087101 as per MCA.
When was Curepro Parenterals Limited incorporated?
Curepro Parenterals Limited was incorporated 13 years 1 month ago on 19 Apr 2013.
What is paid-up capital and authorised share capital of Curepro Parenterals Limited?
The paid-up capital of Curepro Parenterals Limited is ₹ 133,101,070.00 and authorised share capital is ₹ 200,000,000.00.
Who are the current board members and directors of Curepro Parenterals Limited?
Currently 6 directors are associated with Curepro Parenterals Limited: Madan Mohan Reddy Mettu, Sivakumaran Meenakshisunderam, Srinivasarao Devathi, Bhanu Murthy Chavali, Venkat Reddy Kupireddy, Sarath Chandra Reddy Penaka.
  • Madan Mohan Reddy Mettu
  • Sivakumaran Meenakshisunderam
  • Srinivasarao Devathi
  • Bhanu Murthy Chavali
  • Venkat Reddy Kupireddy
  • Sarath Chandra Reddy Penaka
What is the registered address of Curepro Parenterals Limited?
As per Ministry of Corporate Affairs (MCA), the registered address of Curepro Parenterals Limited is Plot No.2, Maitrivihar Ameerpet, Hyderabad, Telangana, 500038, India.
What is the official website of Curepro Parenterals Limited?
The official website of Curepro Parenterals Limited is https://aurobindo.com.
What is the ROC code of Curepro Parenterals Limited?
Curepro Parenterals Limited ROC code is Roc Hyderabad.
What is the company classification of Curepro Parenterals Limited?
Curepro Parenterals Limited is classified as Public Limited Indian Non-Government Company.
Curepro Parenterals Limited - is it listed or unlisted?
Curepro Parenterals Limited is a Unlisted company.
Does Curepro Parenterals Limited have subsidiaries?
Curepro Parenterals Limited has 1 subsidiary record(s) in available group structure data. See the Ownership section for group structure detail.
What is the current status of Curepro Parenterals Limited?
Curepro Parenterals Limited is currently Amalgamated and registered in Hyderabad, Telangana, India.
What industry or business activity is Curepro Parenterals Limited associated with?
Curepro Parenterals Limited lists activity aligned with: Pharma - Drug Formulation & Development - Manufacturing. See the Overview and Competition sections for fuller industry context.
How do I contact Curepro Parenterals Limited?
Use the official website at https://aurobindo.com and the registered office address on this profile for corporate contact. Infyner does not publish personal customer-care numbers unless they appear in sourced company records.
What is the turnover or revenue of Curepro Parenterals Limited?
Turnover and revenue appear in filed financial statements when available. Open the Financial tab on this profile for revenue, profit or loss, balance sheet metrics, and related MCA filings - not headline estimates.
How can I get the financial details of Curepro Parenterals Limited?
You can view revenue, profit or loss, balance sheet metrics, and related filings on the Financial tab of this company profile.
What is the net worth of Curepro Parenterals Limited (last filed snapshot)?
As per the latest financial snapshot on file for FY 2019, net worth is about ₹ 197.84 Cr. Verify figures on the Financial tab and supporting filings.